Evidence mapPaperPMID 38801771Full record

ArticleJMIR research protocols2024

Evaluation of Artificial Intelligence Algorithms for Diabetic Retinopathy Detection: Protocol for a Systematic Review and Meta-Analysis.

Jaime Angeles Sesgundo Iii, David Collin Maeng, Jumelle Aubrey Tukay, Maria Patricia Ascano, Justine Suba-Cohen, Virginia Sampang

Abstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jaime Angeles Sesgundo Iii *Office of Medical Research, University of Nevada, Reno School of Medicine, Reno, NV, United States.ORCID 0009-0001-2470-5895
David Collin Maeng *Office of Medical Research, University of Nevada, Reno School of Medicine, Reno, NV, United States.ORCID 0009-0002-9534-3382
Jumelle Aubrey TukayKirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, United States.ORCID 0009-0004-5481-9385
Maria Patricia AscanoCollege of Osteopathic Medicine, Touro University Nevada, Henderson, NV, United States.ORCID 0009-0001-0779-3715
Justine Suba-CohenGraduate Medical Education Consortium, Valley Health System, Las Vegas, NV, United States.ORCID 0009-0008-1707-810X
Virginia SampangDepartment of Family & Community Medicine, Penn State College of Medicine, Hershey, PA, United States.ORCID 0009-0009-7935-0110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic retinopathy (DR) is one of the most common complications of diabetes mellitus. The global burden is immense with a worldwide prevalence of 8.5%. Recent advancements in artificial intelligence (AI) have demonstrated the potential to transform the landscape of ophthalmology with earlier detection and management of DR.

objectiveThis study seeks to provide an update and evaluate the accuracy and current diagnostic ability of AI in detecting DR versus ophthalmologists. Additionally, this review will highlight the potential of AI integration to enhance DR screening, management, and disease progression.

methodsA systematic review of the current landscape of AI's role in DR will be undertaken, guided by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) model. Relevant peer-reviewed papers published in English will be identified by searching 4 international databases: PubMed, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials. Eligible studies will include randomized controlled trials, observational studies, and cohort studies published on or after 2022 that evaluate AI's performance in retinal imaging detection of DR in diverse adult populations. Studies that focus on specific comorbid conditions, nonimage-based applications of AI, or those lacking a direct comparison group or clear methodology will be excluded. Selected papers will be independently assessed for bias by 2 review authors (JS and DM) using the Quality Assessment of Diagnostic Accuracy Studies tool for systematic reviews. Upon systematic review completion, if it is determined that there are sufficient data, a meta-analysis will be performed. Data synthesis will use a quantitative model. Statistical software such as RevMan and STATA will be used to produce a random-effects meta-regression model to pool data from selected studies.

resultsUsing selected search queries across multiple databases, we accumulated 3494 studies regarding our topic of interest, of which 1588 were duplicates, leaving 1906 unique research papers to review and analyze.

conclusionsThis systematic review and meta-analysis protocol outlines a comprehensive evaluation of AI for DR detection. This active study is anticipated to assess the current accuracy of AI methods in detecting DR. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/57292.

Indexed as

Artificial IntelligenceDiabetic RetinopathyMeta-Analysis as TopicSystematic Reviews as TopicAlgorithmsHumansaccuracyAIAI algorithmsartificial intelligencecomplicationdeep learningdetectiondiabetesdiabetes mellitusdiabetic retinopathyDMDRearly detectionimagingmanagementmeta-analysisophthalmologistsophthalmologyOptharetinopathyscreeningsystematic review

Identifiers

PMID38801771
PMCPMC11165278

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.